Lakiea Wright, MD: Managing Symptoms of Allergic Asthma
An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.
Related Articles
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Schultz discussed the SCtalk trial and its findings at ASH 2024.
Hepatology Month in Review: December 2024
The December month in review spotlights hepatic FDA news as well as the latest research in viral hepatitis and MASH.
Retinal Alterations Reveal Insights Into Schizophrenia, Sclerosis Risk
A recent study showed expression profiles of amacrine cells, the interneurons within the retina, were enriched in schizophrenia genetic risk factors.
Endocrinology Month in Review: December 2024
Our Endocrinology Month in Review for December 2024 highlights recent headlines in diabetes and endocrinology and 4 new episodes of Diabetes Dialogue.
Polypill Therapy Cost-Effective for CVD Risk in Underserved Populations
An economic analysis highlights a cardiovascular polypill’s potential to lower healthcare costs and address income-based health disparities.
Alcohol-Associated Liver Disease, MASLD Drive Growing Liver Cancer Burden in the US
From 2000 to 2021, primary liver cancer incidences and deaths in the US increased by more than 100%, driven by rapid growth in ALD and…
New Phase 2a Findings Released on IMG-007 Treatment of Atopic Dermatitis
New topline data released by Inmagene indicate positive findings from a phase 2a trial on IMG-007 for moderate-to-severe atopic dermatitis.
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Hosted by Skin of Color Society and produced by HCPLive, Skin of Color Savvy delves into the latest research, clinical insights, and culturally competent care…
Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure
Submission of the supplemental NDA was based on positive findings from the FINEARTS-HF trial investigating finerenone for heart failure with an LVEF ≥40%.
FDA Grants Orphan Drug Designation to CNP-104 for Primary Biliary Cholangitis
The designation follows positive topline data from the phase 2a trial of CNP-104 in PBC, which were presented at AASLD’s The Liver Meeting